Incannex Healthcare Inc: Why Investors Shouldn’t Get Rid Of IXHL Stock In 2025

In the last trading session, 0.64 million shares of the Incannex Healthcare Inc (NASDAQ:IXHL) were traded, and its beta was 2.23. Most recently the company’s share price was $0.13, and it changed around $0.0 or -1.28% from the last close, which brings the market valuation of the company to $3.61M. IXHL currently trades at a discount to its 52-week high of $3.55, offering almost -2630.77% off that amount. The share price’s 52-week low was $0.12, which indicates that the current value has risen by an impressive 7.69% since then.

Incannex Healthcare Inc (NASDAQ:IXHL) trade information

Instantly IXHL has showed a red trend with a performance of -1.28% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.1640 on recent trading dayincreased the stock’s daily price by 20.73%. The company’s shares are currently down -93.82% year-to-date, but still down -78.52% over the last five days. On the other hand, Incannex Healthcare Inc (NASDAQ:IXHL) is -79.35% down in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -130.90%.

IXHL Dividends

Incannex Healthcare Inc’s next quarterly earnings report is expected to be released in June.

AdvisorShares Trust-AdvisorShares Psychedelics ETF and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 295.03 shares worth $38649.0, making up 1.07% of all outstanding shares. On the other hand, Bridgeway Funds, Inc.-Ultra-Small Company Market Fund held roughly 25.0 shares worth around $3274.0, which represents about 0.09% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.